Pancreatic Cancer Research

ResearcherLeiden University Medical CenterActive in the last 2 years

Lukas J.A.C. Hawinkels

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2274-9325; OpenAlex author ID A5060111407. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
45
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 2 papers

Papers 11

  1. The closer, the better: intratumoral delivery of a thermoresponsive gemcitabine-loaded hydrogel in preclinical PDAC models. Last author DOI 10.1007/s13346-026-02187-6↗
  2. Bulk RNA sequencing deconvolution of early-onset pancreatic ductal adenocarcinoma identifies cancer-associated fibroblast subsets associated with survival and … Co-author DOI 10.1016/j.ctarc.2026.101490↗
  3. ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts to reovirus. Co-author DOI 10.1016/j.omton.2025.201071↗
  4. Revolutionizing Solid Tumor Surgery with Fibroblast Activation Protein (FAP)-Targeted Imaging Probes for a Fluorescence-Guided Surgery of Pancreatic Cancer. Co-author DOI 10.1021/acs.bioconjchem.5c00218↗
  5. High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in pancreatic cancer. Co-author DOI 10.1002/path.6212↗
  6. Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures. Co-author DOI 10.1016/j.ebiom.2024.105219↗
  7. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer. Last author DOI 10.3390/ijms24108707↗
  8. A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation. First author DOI 10.1016/j.gastha.2022.04.019↗
  9. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical mode… Co-author DOI 10.1136/gutjnl-2021-324834↗
  10. Prostate-Specific Membrane Antigen Targeted Pet/CT Imaging in Patients with Colon, Gastric and Pancreatic Cancer. Co-author DOI 10.3390/cancers14246209↗
  11. Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model. Last author DOI 10.2147/ott.s322276↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vera Kemp · 3 shared papers, 2024–2026 · strength 0.73
  2. Nicole Dam · 2 shared papers, 2025–2026 · strength 0.58
  3. Tom J. Harryvan · 2 shared papers, 2022–2025 · strength 0.41
  4. Alexander L. Vahrmeijer · 2 shared papers, 2022–2025 · strength 0.36
  5. Imke Stouten · 1 shared paper, 2023 · strength 0.31
  6. Bram W. van Os · 1 shared paper, 2026 · strength 0.30
  7. Willem de Koning · 1 shared paper, 2026 · strength 0.30
  8. Gaby J. Strijk · 1 shared paper, 2026 · strength 0.30
  9. Casper H.J. van Eijck · 1 shared paper, 2026 · strength 0.30
  10. Mark J.A. Schoonderwoerd · 2 shared papers, 2021–2022 · strength 0.27
  11. Andrea Vallés‐Martí · 1 shared paper, 2026 · strength 0.26
  12. Helena M. Kelly · 1 shared paper, 2026 · strength 0.26
  13. Marije Slingerland · 2 shared papers, 2021–2022 · strength 0.26
  14. Lysanne D. A. N. de Muynck · 1 shared paper, 2025 · strength 0.25
  15. Ruben D. Houvast · 1 shared paper, 2025 · strength 0.25
  16. Yann Seimbille · 1 shared paper, 2025 · strength 0.25
  17. Hanyue Ma · 1 shared paper, 2025 · strength 0.25
  18. J. Sven D. Mieog · 1 shared paper, 2025 · strength 0.25
  19. Rémy Nicolle · 1 shared paper, 2024 · strength 0.17
  20. Jean‐Luc Van Laethem · 1 shared paper, 2024 · strength 0.17
  21. Richard Tomasini · 1 shared paper, 2024 · strength 0.17
  22. Christelle Bouchart · 1 shared paper, 2024 · strength 0.17
  23. Ellis Michiels · 1 shared paper, 2024 · strength 0.17
  24. Sandrina Martens · 1 shared paper, 2024 · strength 0.17
  25. Nouredin Messaoudi · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.